Global X Genomics & Biotechnology ETF Rating $44.12 +1.75 (+4.13%) As of 10:28 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.64Holdings in GNOM have an aggregate rating of Moderate Buy based on 406 analyst ratings issued in the past year covering 23 companies (78.7% of the portfolio).GNOM Aggregate Price Target$44.12High Prediction$44.12Average Prediction$44.12Low Prediction$44.12Holdings in GNOM have an aggregate price target of $44.12 and a range of $44.12 to $44.12 covering 23 companies (78.7% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.17%CRSPCRISPR Therapeutics$70.42-1.9%1.5271 of 5 stars2.42$71.71 1.8%19News CoverageAnalyst ForecastInsider Trade6.00%ALNYAlnylam Pharmaceuticals$485.68+3.3%4.014 of 5 stars2.82$457.08 -5.9%28Trending NewsAnalyst ForecastAnalyst Revision5.25%RNAAvidity Biosciences$50.05-0.8%2.016 of 5 stars2.95$68.32 36.5%204.54%GHGuardant Health$67.63+5.4%3.5667 of 5 stars2.92$65.86 -2.6%244.28%ARWRArrowhead Pharmaceuticals$39.45+3.3%3.8616 of 5 stars2.78$43.14 9.4%94.02%ILMNIllumina$96.07+3.3%4.7905 of 5 stars2.15$123.56 28.6%20Trending NewsAnalyst Revision3.79%TECHBio-Techne$61.95+4.0%4.788 of 5 stars2.63$70.58 13.9%16Trending NewsAnalyst ForecastAnalyst Revision3.70%NTRANatera$183.68+2.4%2.4063 of 5 stars2.90$194.06 5.7%20Analyst Forecast3.52%QGENQiagen$48.31+1.7%4.2983 of 5 stars2.25$49.40 2.3%123.29%MRNAModerna$28.31+2.1%4.2635 of 5 stars2.00$40.93 44.6%223.28%WGSGeneDx$122.92+5.1%2.2776 of 5 stars2.50$104.13 -15.3%10News Coverage3.27%QUREuniQure$63.24+0.7%3.1968 of 5 stars2.83$71.75 13.5%122.98%LEGNLegend Biotech$33.56-0.5%2.8158 of 5 stars2.73$69.25 106.4%11News Coverage2.89%BNTXBioNTech$106.12+1.7%2.1968 of 5 stars2.64$134.32 26.6%14Analyst Forecast2.79%VCYTVeracyte$35.73+2.7%3.7011 of 5 stars2.67$40.90 14.5%12News Coverage2.76%BMRNBioMarin Pharmaceutical$52.86-0.4%4.9286 of 5 stars2.55$93.26 76.4%22Analyst Revision2.69%RAREUltragenyx Pharmaceutical$33.92+1.5%4.4524 of 5 stars2.77$81.50 140.3%13Trending NewsInsider TradeAnalyst Revision2.67%VRTXVertex Pharmaceuticals$409.55+0.4%4.7994 of 5 stars2.62$494.38 20.7%29Positive NewsAnalyst Revision2.58%NTLAIntellia Therapeutics$26.19+1.0%3.6483 of 5 stars2.52$27.95 6.7%21Gap Up2.49%BEAMBeam Therapeutics$28.03+3.1%3.1301 of 5 stars2.94$45.92 63.8%162.12%AAgilent Technologies$142.46+2.0%3.9895 of 5 stars2.67$149.62 5.0%15Analyst ForecastAnalyst Revision1.87%TWSTTwist Bioscience$32.09+0.1%3.8144 of 5 stars2.58$48.50 51.2%12Analyst RevisionGap Up1.74%GILDGilead Sciences$120.17+1.6%4.8819 of 5 stars2.86$118.08 -1.7%29Positive News This page (NASDAQ:GNOM) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
